Pharmaceutical industry – Page 53
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business
Pharma industry 'strategic crisis'
The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
-
Business
Wellcome Trust launches investment wing
Trust provides £200 million to create Syncona, which will support innovative healthcare businesses
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
OpinionFear of the unknown
How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe
-
Business
Gilead buys YM for $510m
Deal gives Gilead access to Janus kinase inhibitor CYT387 for the treatment of myelofibrosis
-
Business
Pfizer's lost gold
A stash of gold dust bought for $700,000 last year has gone missing from a Pfizer lab in St Louis, Missouri, US
-
Business
Return on drug R&D dropping
The pharma industry is getting less and less return on investment in R&D but trend seems to be bottoming out
-
Business
Baxter to pay $4bn for dialysis firm
Gambro makes products for hemodialysis and continuous renal replacement therapy
-
Business
Drug R&D costs rising
Review from UK consultancy suggests ten-fold increase in per medicine R&D costs over last 30 years
-
Business
GSK expands in India and Nigeria
Company has struck deals to increase ownership of subsidiaries
-
OpinionFull disclosure?
The pharma industry should be more open with its trial data, says Derek Lowe
-
Business
Roche and the Tamiflu data
Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening
-
BusinessRecord insider trading case hits pharma
US authorities claim that hedge fund manager made illicit gains of $276 million in response to confidential clinical trial data
-
Business
BASF bids €664m for omega-3 company
Pronova BioPharma makes pharmaceutical ingredients as well as nutritional supplements based in omega-3 fatty acids
-
Business
Reckitt steps into Schiff deal
Higher bid could sink Bayer’s $1.2bn attempt to buy vitamins and nutritional supplements company